Recipients of the Award for Sustained Contributions

Rhonda Cooper-DeHoff, Pharm D, MS, FAHA, FACC, FCCP
University of Florida 
Gainesville, FL
Brian L. Erstad, Pharm.D.
University of Arizona College of Pharmacy
Tucson, AZ
Watch the awards video now.


C. Michael White, Pharm.D., FCP, FCCP
University of Connecticut School of Pharmacy
Storrs, CT
Watch the awards video now.
Joseph T. Hanlon, Pharm.D., M.S.
University of Pittsburgh
Pittsburgh, PA
Watch the awards video now.   
Glen T. Schumock, B.S.Pharm., Pharm.D., M.B.A., Ph.D.
Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago
Chicago, IL
Watch awards video.
Marie A. Chisholm-Burns, Pharm.D., M.P.H., M.B.A.
University of Tennessee Health Science Center
College of Pharmacy
Memphis, Tenn.
Watch Dr. Chisholm-Burns accept her award.
Mary H. H. Ensom, B.S.Pharm., Pharm.D.
University of British Columbia
Children’s and Women’s Health Centre of British Columbia
Vancouver, British Columbia, Canada
Watch Dr. Ensom accept her award.
Christine A. Sorkness, Pharm.D.
University of Wisconsin School of Pharmacy
Madison, Wis.
Joseph F. Dasta, M.Sc., FCCM, FCCP

The Ohio State University, College of Pharmacy and
University of Texas at Austin, College of Pharmacy
Roland N. Dickerson, Pharm.D., BCNSP
University of Tennessee Health Science Center
Memphis, Tenn.

William D. Figg, Sr., Pharm.D., M.B.A.
Senior Scientist & Section Head
National Cancer Institute
Medical Oncology Branch, Molecular Pharmacology Section
Bethesda, Md.

Dr. Figg has served since 1993 as Senior Scientist & Section Head of the National Cancer Institute’s Medical Oncology Branch, Molecular Pharmacology Section. More recently, the Clinical Pharmacology Research Core and the Preclinical Pharmacology Research Core were formed, which he also heads. Dr. Figg has focused his research on utilizing pharmacological principles in anticancer drug development and evaluating novel new agents in the treatment of cancer of the prostate. He has published more than 350 peer-reviewed publications, which have made significant advances in understanding cancer, the genetic risk factors and advancing our treatment options. Dr. Figg is a captain in the U.S. Public Health Services’ Commissioned Corps.
John G. Kuhn, B.S., Pharm.D., FCCP, BCOP

Professor of Pharmacy
College of Pharmacy, The University of Texas at Austin and University of Texas Health Science Center at San Antonio, Texas

Dr. Kuhn has made a sustained contribution to the biomedical literature consistently on high-impact journals and of clinical relevance over the past 28 years. Dr. Kuhn has been the primary or corresponding author or made a significant contribution to 154 primary publications, 30 book chapters and 209 abstracts.
John D. Grabenstein, Ph.D., Ed.M., M.S.Pharm., R.Ph., FASHP

Director, Military Vaccine Agency
Office of Army Surgeon General
Falls Church, Va.

Dr. John D. Grabenstein, the 2006 recipient of the Award for Sustained Contribution to the Literature of Pharmacy Practice, believes that this award “recognizes how important it is for pharmacists to get involved with immunizations for the people they serve, whether this is through drug information, clinical advocacy, or drug administration.”  Dr. Grabenstein’s publications over the past 20 years have focused on topics of immunization, which he hopes will “lead pharmacists to attend to the adequacy of the immunizations they and their own families receive, and then reach out to their patients to provide comparable protection.”

Robert L. Talbert, Pharm.D.

Professor, Pharmacotherapy Division
University of Texas, College of Pharmacy
San Antonio, Texas

Dr. Talbert currently holds an endowed professorship at the University of Texas, College of Pharmacy in Austin and the University of Texas Health Science Center in San Antonio. His scholarly contributions have been sustained over a 31-year professional career, averaging five publications per year. His significant contributions as a clinical pharmacy investigator and contributing author have appeared in high-impact pharmacy and medicine journals. He is a content expert in the areas of heart, thyroid and lipid disorders. His best-known contributions to the literature are the textbook Pharmacotherapy: A Pathophysiological Approach and Pharmacotherapy Casebook: A Patient-Focused Approach.

Sarah A. Spinler, Pharm.D., FCCP

Department of Pharmacy Practice and Pharmacy Administration
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, Pa.

Dr. Spinler, a nationally known expert on cardiovascular pharmacotherapy, has given more than 200 national presentations to health care audiences and has published numerous peer-reviewed papers. Her work in ways to improve long-term survival and quality of life after heart attacks has been widely disseminated and extensively referenced.

John E. Murphy, Pharm.D.

Department of Pharmacy Practice and Science
College of Pharmacy
University of Arizona
Tucson, Ariz.

Dr. Murphy is known in the College for his belief in service to the institution and professional organizations and champions that cause in working with faculty and students. Dr. Murphy's contributions have spanned many years and a variety of topics across a number of professional organizations and journals. He has supervised the required research projects of 20 doctor of pharmacy students at the University of Arizona College of Pharmacy, which is more than the average number of other faculty members. More than half of these have been presented nationally and/or published, which is much, much more than the average, and is a reflection of the time and dedication Dr. Murphy puts forth in this process. Dr. Murphy has published a number of articles in pharmacokinetics, and has a special ability to translate difficult pharmacokinetic concepts into practical verbal and written information desired by clinicians.

Michael J. Rybak, Pharm.D., FCCP, BCPS

University Health Center
Anti-Infective Research Laboratory
Wayne State University
Detroit, Mich.

Dr. Rybak's practice, teaching and research have focused on the in-vitro and in-vivo study of antimicrobial pharmacodynamics and pharmacokinetics and resistance. His contributions to the infectious disease and health-system literature span more than 20 years. Dr. Rybak is scientific editor for Pharmacotherapy and has been on the editorial panel of several other journals, including the American Journal of Health-System Pharmacy, Annals of Pharmacotherapy, and Antimicrobial Agents and Chemotherapy.

Laurie L. Briceland, Pharm.D., FASHP, FCCP

Albany College of Pharmacy
Albany, N.Y.

Dr. Briceland has published widely in the pharmaceutical and medical literature. Her chief areas of interest are pharmacy practice research, experiential education, medication prescribing errors and antimicrobial pharmacotherapy and management.

Gary R. Matzke, Pharm.D.
Professor of Pharmaceutical Sciences and Medicine
Univeristy of Pittsburgh School of Pharmacy
Pittsburgh, Pa.

Matzke's chief field of interest is the effects of renal disease and dialysis on the pharmacokinetics and pharmacodynamics of therapeutic agents. He has translated his research findings into clinical therapeutic reviews that have enhanced the quality of care for patients with renal disease.

Arthur G. Lipman, Pharm.D., FASHP

University of Utah College of Pharmacy
Salt Lake City, Utah

Dr. Lipman's efforts have focused on institutional pharmacy practcie with additional emphasis on pain management and care for terminally ill patients. Throughout his career, Dr. Lipman has served as professor, consultant, author, edictor and presenter for projects addressing hospice, long-term care and pain treatment.

Michael R. Cohen, M.S., FASHP

Institute for Safe Medication Practices
Warminster, Pa.

Mr. Cohen's efforts have focused on implementing a multidisciplinary approach to eliminating medication errors. He is notable for first applying failure mode and effects analysis to medication use. His writing has been integrated with broader educational and advocacy efforts focused on improving the safety of medication use. Mr. Cohen has been an assistant editor of Hospital Pharmacy for many years, and has contributed to other journals, newsletters and books in various health professions. As the editor of Error Alert!, Cohen has proposed ways for health systems to better serve patients. His writings have influenced numerous practitioners and stimulated improvements in medication products and medication-use processes in health systems.

Charles D. Hepler, Ph.D.

University of Florida
Gainesville, Fla.

Dr. Hepler's efforts have focused on the social and behavioral aspects of therapeutics, with emphasis on pharmaceutical care in health services organizations. He has also served as an educator, consultant, author and editor for projects addressing decision-making, systems analysis and management, and sociology of professions.

Lawrence A. Trissel, FASHP
University of Texas, M.D. Anderson Cancer Center
Houston, Texas

Mr. Trissel's efforts have focused on compiling summary information on drug compatibilities and making it readily accessible to practicing pharmacists. Most notable are his publications, Trissel's Stability of Compounded Formulations, Trissel's Tables of Physical Compatibility, and both the Pocket Guide and the Handbook on Injectable Drugs. In addition, he has widely published original research in the areas of drug stability and compatibility.

Barry L. Carter, Pharm.D.
University of Colorado Health Sciences Center
Denver, Colo.

Dr. Carter specializes in pharmaceutical care in the ambulatory enviornment, notably family medicine and other pharmacist-managed clinics, administrative issues and program development. His clinical studies have focused primarily on hypertension and cardiovascular therapeutics. He has authored or coauthored 6 books; 29 refereed research publications; 29 review articles and case reports; more than 50 national or international presentations; and has been involved in numerous national committee reports, editorials, book reviews and chapters.

David B. Brushwood

University of Florida College of Pharmacy
Gainesville, Fla.

C. Lindsay DeVane
University of Florida College of Pharmacy
Gainesville, Fla.

Joseph T. DiPiro, Pharm.D.
Professor of Pharmacy
Medical College of Georgia
Augusta, Ga.

Dr. DiPiro received this award in recognition of his achievements as a researcher and author, especially in the field of infectious disease drug therapy. During the 1980s, Dr. DiPiro established himself as one of the country's experts on antimicrobial use, especially for surgical prophylaxis. Dr. DiPiro has served as an author, editor or reviewer for more than 80 publications and is noted for his contributions to the widely used textbook, Pharmacotherapy: A Pathophysiologic Approach. His current research involves the immunologic aspects of infectious diseases, focusing on the role of monoclonal antibodies.

Thomas S. Foster

Director, Center for Pharmaceutical Science and Technology
Professor of Pharmacy, College of Pharmacy, University of Kentucky, Lexington
Lexington, Ky.

Dr. Foster received this award in recognition of his achievements as a researcher and author, most notably in the areas of bioavailability, efficacy, pharmacokinetics, and other clinical studies involving a wide array of drugs. Over the past 16 years, Dr. Foster has served as author or co-author for more than 83 professional publications.

James W. Cooper, Jr., Ph.D.

Professor and Head, Department of Pharmacy Practice and Director of Pharmacy, College of Pharmacy, University of Georgia
Assistant Clinical Professor, Department of Family Medicine, Medical College of Georgia Athens, Ga.

Dr. Cooper received this award in recognition of his contributions to both the professional and research literature. He has authored  or co-authored more than 66 research papers, notably in the areas of geriatric drug therapy efficacy and toxicity and pharmacoepidemiology. His numerous professional publications, including books, reviews and abstracts, have often focused on the impact of the consultant pharmacist n health care, and, especially long-term facilities.

Jerome J. Schentag, Pharm.D.

Director, The Clinical Pharmacokinetics Laboratory, Millard Fillmore HospitalProfessor of Pharmaceutics and Pharmacy, Division of Clinical Pharmacy Services, State University of New York at Buffalo
Buffalo, N.Y.

Dr. Schentag received this award in recognition of his achievements as a researcher and author in the area of clinical pharmacokinetics. He has published 132 articles, most of which are original research papers, and has also contributed to or edited 22 books related to drug therapy. Dr. Schentag currently serves as a manuscript reviewer for 24 journals and is a member of the editorial advisory board for four publications. His research is devoted to the clinical applications of pharmacokinetic and physiologic models, and encompasses correlations between phamacokinetic parameters and biolgic response to disease, drug efficacy and toxicity. He has approached his profession with a special focus on expanding the role of pharmacists in clinical and research areas.

No award was given in this year.

Milhap C. Nahata, Pharm.D.

Associate Professor, Division of Pharmacy Practice
The Ohio State University College of Medicine, Children's Hospital
Columbus, Ohio

Dr. Nahata received this award in recognition of his achievements as a researcher and author in the areas of pharmaceutics, pharmacokinetics, pediatrics, geriatrics and infectious disease in the professional pharmaceutical, medical and health-related literature. During the past 10 years, he has been the author or co-author of more than 100 articles published in refereed professional journals. He has made more than 150 presentations at various international, national, state and local meetings.

Darwin E. Zaske, Pharm.D.

Director, Pharmaceutical Services, St. Paul-Ramsey Medical Center, St. Paul, Minn.
Professor, University of Minnesota College of Pharmacy, Minneapolis, Minn.

Dr. Zaske received this award in recognition of his achievements as a researcher and author in the areas of pharmacokinetics of various drugs, drug administration, pharmaceutical services, computer applications, revenue enhancement and cost analysis of clinical services, and antibiotic therapy. During the past 10 years, he has been the author or co-author of more than 45 articles published in refereed professional journals. He has also written 15 chapters in various texts and reference books and made numerous contributions to association and trade publications.

Dennis K. Helling, Pharm.D.

Associate Professor and Head, Division of Clinical/Hospital Pharmacy
College of Pharmacy, The University of Iowa
Iowa City, Iowa

Dr. Helling received this award in recognition of his achievements as a researcher and author in the areas of interdisciplinary health care delivery, drug-use review, evaluation of clinical services by pharmacists, multidisciplinary gerontology training and service effectiveness and patient self-medication. He has authored or coauthored in the last 13 years more than 40 published articles in refereed professional journals, as well as 7 chapters in various professional texts and reference books. In addition, he has contributed numerous articles to assocation and trade publications and conference proceedings.

Edward G. Nold, M.S.

Director of Pharmaceutical Services
University of Chicago Medical Center
Chicago, Ill.

Over the past several years, Mr. Nold has authored or coauthored numerous articles dealing with financial management of hospital pharmacy operations, management of hospital pharmacy computer systems, development and operation of hospital pharmacy service programs, bar code applications in hospital pharmacy, personnel management in hospital pharmacy, and related topics dealing with hospital pharmacy administration.

Peter P. Lamy, Ph.D., F.A.G.S.

Professor and Director, The Center for the Study of Pharmacy and Therapeutics for the Elderly
Director, Institutional Pharmacy Programs
Chairman, Department of Pharmacy Practice and Administrative Science, School of Pharmacy, University of Maryland
Baltimore, Md.

William A. Gouveia

Please note that prior to 1982, the Award for Sustained Contributions to the Literature of Pharmacy Practice was known as the "Award for Achievement in the Professional Practice of Hospital Pharmacy," and there were two recipients: One for hospitals with more than 400 beds, and one for hospitals with fewer than 400 beds.

More than 400 Beds
Louis P. Jeffrey, Sc.D.
For sustained contributions to the literature of hospital pharmacy

Fewer than 400 Beds
Christopher S. Conner, Kelly J. Murphrey, Dennis Sawyer, Kathy Murakami, Barry H. Rumack and Pamela S. Ford
"Drug Information Services for Consumers and Health Professionals"

More than 400 Beds
William E Smith and Jack W. Weiblen
"Charging for Hospital Pharmaceutical Services: Product Cost, Per Diem Fees and Fees for Special Clinical Services

Fewer than 400 Beds
Arthur G. Lipman, Jan N. Bair, F. James Hibbard, John A. Bosso and John Russo, Jr.
"Decentralization of Pharmaceutical Services Without Satellite Pharmacies"

More than 400 Beds
Richard P. Hoffman
For sustained quality of publications over several years

Fewer than 400 Beds
Larry E. Patterson and Ronald J. Huether
"Reimbursement for Clinical Pharmaceutical Services"

More than 400 Beds
Lawrence A. Trissel
"Handbook on Injectable Drugs"

Fewer than 400 Beds
P. Allen Frisk, James W. Cooper, Jr., and Norman A. Campbell
"Community-Hospital Pharmacist Detection of Drug-Related Problems Upon Patient Admission to Small Hospitals"

More than 400 Beds
Russell R. Miller
For sustained quality of publications over several years

Fewer than 400 Beds
David J. Tanner
"Comprehensive Pharmacy Services in an 85-Bed Hospital"

More than 400 Beds
Elvin G. Curtis and Jayant A. Patel
"Pharmacy-Based Analytical Toxicology Service"

Fewer than 400 Beds
Thomas P. Reinders, David R. Rush, R. Paul Baumgartner, Jr., and Allan W. Graham
"Pharmacist's Role in Management of Hypertensive Patients in an Ambulatory Care Clinic"

More than 400 Beds
William A. Miller
"Selection, Training and Evaluation of Clinical Pharmacists"

Fewer than 400 Beds
David K. Solomon, R. Paul Baumgartner, Jr., Lyle M. Glascock, May E. Briscoe, Norman F. Billups
"Use of Medication Profiles to Detect Potential Therapeutic Problems in Ambulatory Patients"

More than 400 Beds
William E. Smith
"The Economic Feasibility of Clinical Pharmacy in the Hospital Setting 1: Personnel Costs"

Fewer than 400 Beds
Robert W. Bennett, Bobbie G. Bryant, Allan L. Kelly, Jane D. Weida
"Development of a Pharmacy Care Plan"

More than 400 Beds
Robert E. Pearson, William Schmalgemeier, Melinda Bendall, Persis Mehta, Vern F. Thudium and George T. Phillips
"Michigan Regional Drug Information Network, Part III: Utilization of Information Center"
"Michigan Regional Drug Information Network, Part IV: Description and Evaluation"

Fewer than 400 Beds
Brian J. Ellinoy, John S. Shuster, James C. Yatsco and Lawrence C. Rosenthal
"Pharmacy Audit of Patient Health Records -- Feasibility and Usefulness of a Drug Surveillance System"

More than 400 Beds
Herbert L. Flack, John A. Gans, Stanley E. Serlick and Stanley J. Dudrick
"The Current Status of Parenteral Hyperalimentation"

Fewer than 400 Beds
R. David Anderson
"The Physician's Contribution to Hospital Medication Errors"

More than 400 Beds
Clifton J. Latiolais, Charles C. Berry, Bernard J. Lachner, Ruby M. Martin and Larry K. Shoup
"Pharmacy Coordinated Unit Dose Dispensing and Drug Administration System"

Fewer than 400 Beds
Judy Slining, Philip Cole and Sister Emmanuel
"Development of a Drug Incompatibility File and Its Use in Patient Medication Profile Interviews"